Literature DB >> 19626319

Perfusion differences on SPECT and PWI in patients with acute ischemic stroke.

Juho Nuutinen1, Yawu Liu, Mikko P Laakso, Jari O Karonen, Esko J Vanninen, Jyrki T Kuikka, Hannu J Aronen, Ritva L Vanninen.   

Abstract

INTRODUCTION: The purposes of the present study were to compare the flow defect volumes on perfusion-weighted magnetic resonance imaging (PWI) and (99m)Tc-labeled ethylcysteinate dimer ((99m)Tc-ECD) single photon emission computed tomography (SPECT) at acute and subacute stages of ischemic stroke and to analyze the relationship between the detected flow defects on the two methods and neurological status and clinical outcomes.
METHODS: Perfusion defects on PWI and SPECT were measured within 48 h and on day 8 of the onset of stroke from 22 patients with their first-ever acute supratentorial ischemic stroke. The primary neurological status was evaluated prior to the imaging. Clinical outcome was assessed at 3 months after the onset of the stroke.
RESULTS: The volumes of cerebral blood flow (CBF) defects did not differ between SPECT and PWI within the 48-h examinations. However, the volume of CBF defect was significantly larger on SPECT than on PWI on day 8 (p = 0.03). Within the 48-h examinations, the CBF defect volumes on SPECT and PWI were comparably related to the neurological status. On day 8, the CBF defect volume on SPECT showed higher correlation to the neurological status and more precisely predicted the clinical outcomes at 3 months than PWI.
CONCLUSIONS: (99m)TC-ECD-SPECT and PWI both have ability to detect cerebral hypoperfusion in patients with ischemic stroke but with some differences. The value of SPECT is more accurate in terms of the delayed outcome, such as prognosis and rehabilitation planning.

Entities:  

Mesh:

Year:  2009        PMID: 19626319     DOI: 10.1007/s00234-009-0569-9

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  26 in total

1.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis.

Authors:  L Ostergaard; R M Weisskoff; D A Chesler; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

2.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

3.  Combined SPECT and diffusion-weighted MRI as a predictor of infarct growth in acute ischemic stroke.

Authors:  J O Karonen; J Nuutinen; J T Kuikka; E J Vanninen; R L Vanninen; P L Partanen; P A Vainio; R Roivainen; J Sivenius; H J Aronen
Journal:  J Nucl Med       Date:  2000-05       Impact factor: 10.057

4.  Multicenter trial of hemodilution in ischemic stroke--background and study protocol. Scandinavian Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  1985 Sep-Oct       Impact factor: 7.914

Review 5.  Diaschisis.

Authors:  J S Meyer; K Obara; K Muramatsu
Journal:  Neurol Res       Date:  1993-12       Impact factor: 2.448

6.  Delayed intrahemispheric remote hypometabolism. Correlations with early recovery after stroke.

Authors:  S Iglesias; G Marchal; F Viader; J C Baron
Journal:  Cerebrovasc Dis       Date:  2000 Sep-Oct       Impact factor: 2.762

7.  Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging.

Authors:  A E Baird; A Benfield; G Schlaug; B Siewert; K O Lövblad; R R Edelman; S Warach
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

8.  Combined perfusion- and diffusion-weighted MR imaging in acute ischemic stroke during the 1st week: a longitudinal study.

Authors:  J O Karonen; Y Liu; R L Vanninen; L Ostergaard; P L Kaarina Partanen; P A Vainio; E J Vanninen; J Nuutinen; R Roivainen; S Soimakallio; J T Kuikka; H J Aronen
Journal:  Radiology       Date:  2000-12       Impact factor: 11.105

9.  CO2 response for the brain stem artery blood flow velocity in man.

Authors:  W Hida; Y Kikuchi; S Okabe; H Miki; H Kurosawa; K Shirato
Journal:  Respir Physiol       Date:  1996 Apr-May

10.  99mTc-bicisate reliably images CBF in chronic brain diseases but fails to show reflow hyperemia in subacute stroke: report of a multicenter trial of 105 cases comparing 133Xe and 99mTc-bicisate (ECD, neurolite) measured by SPECT on same day.

Authors:  N A Lassen; B Sperling
Journal:  J Cereb Blood Flow Metab       Date:  1994-01       Impact factor: 6.200

View more
  6 in total

1.  Assessment of baseline hemodynamic parameters within infarct progression areas in acute stroke patients using perfusion-weighted MRI.

Authors:  Thomas Ritzenthaler; Tae-Hee Cho; Marlène Wiart; Julien Berthiller; Leif Østergaard; Marc Hermier; Laurent Derex; Yves Berthezène; Norbert Nighoghossian
Journal:  Neuroradiology       Date:  2010-11-27       Impact factor: 2.804

Review 2.  Acute stroke magnetic resonance imaging: current status and future perspective.

Authors:  Stephan P Kloska; Max Wintermark; Tobias Engelhorn; Jochen B Fiebach
Journal:  Neuroradiology       Date:  2009-12-05       Impact factor: 2.804

3.  Neural Correlates of Motor Recovery Measured by SPECT at Six Months After Basal Ganglia Stroke.

Authors:  Ji Won Choi; Myoung Hyoun Kim; Soon-Ah Park; Deok Su Sin; Min-Su Kim
Journal:  Ann Rehabil Med       Date:  2017-12-28

4.  Comparative study of MR mTI-ASL and DSC-PWI in evaluating cerebral hemodynamics of patients with Moyamoya disease.

Authors:  Jinge Zhang; Chunchao Xia; Yi Liu; Weiqiang Qian; Wanlin Peng; Keling Liu; Lei Li; Fei Zhao; Zhenlin Li
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

5.  Clinical and neuroimaging correlates among cohorts of cerebral arteriostenosis, venostenosis and arterio-venous stenosis.

Authors:  Jiayue Ding; Jingwei Guan; Gary Rajah; David Dornbos; Weili Li; Zhongao Wang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Aging (Albany NY)       Date:  2019-12-02       Impact factor: 5.682

6.  Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.

Authors:  Alessandra D'Amico; Lorenzo Ugga; Sirio Cocozza; Sara Maria Delle Acque Giorgio; Domenico Cicala; Claudia Santoro; Daniela Melis; Giuseppe Cinalli; Arturo Brunetti; Sabina Pappatà
Journal:  Neurol Sci       Date:  2020-07-10       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.